Abstract:Candida auris is a fungal pathogen of humans responsible for nosocomial infections with high mortality rates. High levels of resistance to antifungal drugs and environmental persistence mean these infections are difficult to treat and eradicate from a healthcare setting. Understanding the life cycle and the genetics of this fungus underpinning clinically relevant traits, such as antifungal resistance and virulence, is of the utmost importance to develop novel treatments and therapies. Epidemiological and genomic studies have identified five geographical clades (I-V), which display phenotypic and genomic differences. Aggregation of cells, a phenotype primarily of clade III strains, has been linked to reduced virulence in some infection models. The aggregation phenotype has thus been associated with conferring an advantage for (skin) colonisation rather than for systemic infection. However, strains with different clade affiliations were compared to infer the effects of different morphologies on virulence. This makes it difficult to distinguish morphology-dependent causes from clade-specific or even strain-specific genetic factors. Here, we identify two different types of aggregation: one induced by antifungal treatment which is a result of a cell separation defect; and a second which is controlled by growth conditions and only occurs in strains with the ability to aggregate. The latter aggregation type depends on an ALS-family adhesin which is differentially expressed during aggregation in an aggregative C . auris strain. Finally, we demonstrate that macrophages cannot clear aggregates, suggesting that aggregation might after all provide a benefit during systemic infection and could facilitate long-term persistence in the host. Candida auris is a single-celled fungus, a yeast, that can cause severe infections in hospital patients. This fungus is difficult to treat because it is resistant to many antifungal drugs. Therefore, to understand the processes that enhance the virulence of this yeast with a view to developing new treatments is of the utmost importance. Previous studies have found that C . auris can form aggregates, or clumps of cells, which may play a role in how the fungus infects people. In this study, we identified two different types of aggregation in C . auris , one triggered by antifungal treatment, and another controlled by growth conditions. This discovery allowed us to study aggregate formation in the same genetic background. In doing so, we found that a certain protein, an ALS-family adhesin, is involved in the aggregation process. Surprisingly, we also discovered that aggregates may promote infection by making it harder for the immune system to clear the yeast. This new understanding could help researchers develop better ways to fight C . auris infections.

Interactions of the emerging fungus Candida auris with Acanthamoeba castellanii reveal phenotypic changes with direct implications on the response to stress and virulence

Host–pathogen interactions upon Candida auris infection: fungal behaviour and immune response in Galleria mellonella

Alteration of β-glucan in the emerging fungal pathogen Candida auris leads to immune evasion and increased virulence

Environmental reservoirs of the drug-resistant pathogenic yeast Candida auris

Characterization of susceptibility patterns and adaptability of the newly emerged Candida auris

Yeast and filamentous Candida auris stimulate distinct immune responses in the skin

Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris

Unravelling the interactions of the environmental host Acanthamoeba castellanii with fungi through the recognition by mannose‐binding proteins

Innate immune responses against the fungal pathogen Candida auris

Candida auris undergoes adhesin-dependent and -independent cellular aggregation

Pathogenesis, Prophylaxis, and Treatment of Candida auris

Ume6-dependent pathways of morphogenesis and biofilm formation in Candida auris

The many faces of Candida auris : Phenotypic and strain variation in an emerging pathogen

Decoding host cell interaction– and fluconazole-induced metabolic alterations and drug resistance in Candida auris

A correlative study of the genomic underpinning of virulence traits and drug tolerance of Candida auris

Comparative fitness trade-offs associated with azole resistance in Candida auris clinical isolates

Candida Auris: Epidemiology, Biology, Antifungal Resistance, and Virulence.

Candida auris as a pathogen that can cause emerging infectious disease: a literature review

Candida auris: Epidemiology and Antifungal Strategy

Cell aggregation mediated by ACE2 deletion in Candida auris modulates fungal colonization and host immune responses in the skin

Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4